UPI Study › Courses › Abnormal Psychology › Free lessons › Lesson 3.5 Free with a free account
Medically-Based Interventions, and Weighing the Biological Approach
Abnormal Psychology · Chapter 3: Biological Underpinnings of Psychological DisordersSection 3.5 · lesson 13 of 9718 min · free with a free account
Free preview
Create a free account to keep watching
It takes a minute and costs nothing. Your free account unlocks all of Chapter 1 and 3 more lessons of Abnormal Psychology.
Lesson complete
Earn the 3 college credits for Abnormal Psychology
Enrolling adds a quiz after each lesson, the graded work and the official transcript. Recommended for credit by NCCRS.
Next lesson: Core Concepts of the Psychodynamic Framework →← How Genetics and Evolution Shape Psychological VulnerabilityNext lesson: Core Concepts of the Psychodynamic Framework →
In this lesson
What biological treatment does, how response is judged, and where the approach falls short.
- Describe the main categories of biologically based intervention
- Explain onset, response lag, maintenance, and relapse prevention
- State the merits and the limitations with equal seriousness
- Say why discontinuation is a process rather than an event
Transcript
Everything said in the video, section by section (2,389 words). Read along, or search it.
Biological Underpinnings of Psychological Disorders
Medically-Based Interventions, and Weighing the Model
The last section of the biological chapter, and it does two jobs. First, what biological treatment actually is, described at the level of drug class. How response is judged, and why the first weeks are the hardest. Why stopping a medication is a process rather than an event. Then brain stimulation, described accurately rather than from film. And psychosurgery, which is the most serious cautionary episode in the chapter. Then we weigh the whole biological approach. Merits and limitations, set out with equal seriousness. You will find that each merit casts its own shadow. And the debate about whether biology is the right level is left open, deliberately.
Read This First
No Medication Is Named Anywhere Here
Read this part first, because it is the strictest note in the course. This material is educational, and not a basis for any medication decision. No individual medication, brand, dose, or combination is named anywhere here. And none will be. Mechanisms are described at the level of drug class only. Side effects are described as clinical considerations, not as guidance. Nothing here states what any reader should take, start, stop, or avoid. Any decision to begin, continue, change, or discontinue a prescribed medication. That decision is made with the prescriber. And stopping a prescribed medication abruptly carries real risk. It is unsafe. One line of background. Drugs act by altering the steps of synaptic transmission. Principally through agonist or antagonist action at receptors. And through inhibition of reuptake, or of breakdown.
The Logic
Why Intervening Physically Should Work at All
A biological intervention is any treatment acting on a physiological process. In order to change psychological function. The reasoning follows directly from the biological model. If psychological states are physically implemented, altering the physical process alters the state. Two clarifications keep that logic honest. First, intervening successfully does not demonstrate that the process caused the condition. That is the inference from treatment back to cause. We rejected it when we looked at the chemical imbalance account. It is the same error, in a new setting. Second, a biological intervention is not the opposite of a psychological one. Psychological treatment also produces physical change. So the distinction concerns the route taken, rather than the kind of change produced.
Five Classes
Class Names Map Poorly Onto Diagnoses
Five broad categories cover most psychiatric prescribing. Each is described here at class level, and one thing about the names matters. Each class name describes the presentation it was developed for. Not the only presentation it is used for. Several are routinely used outside their original category. So the class name is an unreliable guide to why a person is taking something. The antidepressant class increases availability of serotonin, norepinephrine, or both. Chiefly by inhibiting reuptake. The anxiolytic class enhances the action of GABA, reducing neural excitability. The mood-stabilizing class is varied and incompletely understood. Several act on ion channels, or on intracellular signaling. The antipsychotic class reduces activity at certain dopamine receptors. Newer agents also act on serotonin receptors. And the stimulant class increases availability of dopamine and norepinephrine. Now compare the onset column, because it splits into two groups. Two classes act within hours. Three take weeks. That split is the most clinically consequential thing in the table. The rapid-onset classes carry tolerance, dependence, or misuse considerations. The slow-onset classes largely do not, and that is not a coincidence. A treatment whose effect is felt immediately is one a person can come to rely on.
Phases
Four Questions, Not One
Response lag is the delay between a drug's immediate action and any change in symptoms. For several classes it runs to weeks. The explanation came earlier. The immediate synaptic change is not the therapeutic effect. That involves slower downstream adaptation, in receptor sensitivity and in plasticity. Four phases are conventionally distinguished. Each one raises a different question, which is why the distinctions matter. The acute phase is the initial period during which response is assessed. The question there is simply whether symptoms improve. The continuation phase is treatment continued after improvement. Because stopping at the point of recovery is associated with the return of symptoms. The question is whether the improvement holds. The maintenance phase is longer-term treatment for people who have had several episodes. The question is whether recurrence is prevented. And relapse means return of the same episode, while recurrence means a new one. Distinguishing them affects whether treatment is resumed, or reconsidered. One general observation is worth stating plainly. Improvement is not the same as remission. Remission is not the same as recovery. And none of them is the same as cure. Much of the debate about how well psychiatric medication works turns on which is measured.
Tolerability
Side Effects Are Expected, Not a Flaw
A side effect is an effect of a treatment other than the intended one. Tolerability is how acceptable those effects are to the person taking it. Both shape outcomes as much as efficacy does. Three points frame them correctly. Side effects are not incidental. A drug acting on a transmitter system acts on that system everywhere it operates. And those systems participate in many functions. So effects beyond the intended one are expected, rather than a manufacturing flaw. Tolerability is a personal judgment, rather than a property of the drug. The same effect is trivial to one person and unacceptable to another. Depending on their work, their relationships, and their priorities. And tolerability drives adherence, which drives outcome. A modest treatment a person keeps taking may beat a stronger one they discontinue. A substantial proportion of prescribed treatment is not taken as intended. Understanding why changes the response. Unwanted effects often arrive before wanted ones. So the early weeks offer burden without benefit, and that is when most stopping happens. Feeling better is itself a common reason for stopping. Which is why the continuation phase is explained at the start, not at recovery. And some effects are not volunteered unless asked about directly.
Discontinuation
A Process, Not an Event
Discontinuation is the process of stopping a medication. And it is a clinical process rather than an event. Three reasons make abrupt cessation unsafe, and they are different from one another. First, discontinuation effects. Stopping several classes suddenly produces physical and psychological effects. Effects distinct from the return of the original condition. They are commonly mistaken for relapse. Which leads to the wrong conclusion about whether the treatment was needed. Second, return of the condition. Where treatment is suppressing symptoms rather than having resolved the difficulty. Stopping can be followed by return, sometimes rapidly. Third, class-specific risks. For some classes, abrupt cessation carries medical dangers. Not described here beyond stating that they exist, and are a matter for the prescriber. So the clinical position is straightforward, and it is stated without qualification. Any decision to stop a prescribed medication is made with the prescriber. Stopping abruptly and without discussion carries risk. A person wanting to stop for good reasons is best served by saying so. And there are often good reasons. A planned withdrawal is available. An unplanned one is the version that goes badly.
Stimulation
Describing ECT Accurately
Electroconvulsive therapy passes a brief electrical current through the brain. Under general anesthesia, to induce a controlled seizure. It requires accurate description, because most people have encountered it from film. Modern practice differs from historical practice in specific ways. It is administered under general anesthesia, with a muscle relaxant. So the person is unconscious, and the visible convulsion is largely suppressed. Electrical dose and placement are controlled, and much lower than in early practice. It is given as a course of sessions over weeks, with consent as for any procedure. Historically it was administered without anesthesia, and at higher doses. Sometimes without consent, and sometimes punitively. That history is real. It is the source of the treatment's reputation. And it should not be waved away. What is it used for? Principally severe depressive conditions that have not responded. And situations where a rapid response is needed. The evidence supports it as among the more effective treatments for severe presentations. It often works faster than medication. The limitations are memory effects, particularly around the treatment period. Usually temporary, and sometimes reported as persistent. That is an area where clinical accounts and personal accounts do not fully agree. Report the disagreement rather than resolving it. Relapse after a successful course is also common without continued treatment. Non-invasive brain stimulation alters activity through the skull, without surgery or seizure. Using magnetic fields, or weak electrical currents. The person stays awake. The evidence supports a real, but generally more modest, effect.
A Cautionary Episode
Psychosurgery, and Three Lessons
Psychosurgery is the surgical alteration of brain tissue to change psychological function. Its history is the most serious cautionary episode in this chapter. In the mid twentieth century, procedures severing connections to the frontal lobes. They were performed on very large numbers of people. The harms were severe and well documented. Profound and permanent personality change. Loss of initiative and emotional range. Cognitive impairment. And deaths. The evidence was as bad as the harm. Consent was frequently absent or nominal. Some procedures were performed on people with limited capacity to refuse. And assessment of success was often made by the surgeon, without controls. Sometimes in terms of how manageable the person had become. Three lessons are worth drawing, and they generalize. Irreversibility raises the evidential bar. A treatment that cannot be undone needs far stronger evidence than one that can be stopped. An outcome measure chosen by the person delivering the treatment is not an outcome measure. That is the assessor-blinding problem, with catastrophic consequences. And the absence of alternatives is a reason for urgency in developing them. It is not a license to proceed without evidence. Modern status. Procedures of that kind are not performed. A very small number of highly targeted neurosurgical procedures exist. For severe, prolonged, treatment-resistant conditions. In a handful of specialist centers, on very few people, and with informed consent.
Combined And Shared
Two Components, and Where the Person Enters
For a number of conditions, combining biological and psychological treatment works better. Better than either component alone. But the pattern is not uniform. It is clearer for some presentations than others, and for some the added benefit is small. So state it as a pattern, rather than as a rule. Where combination helps, the two components contribute different things. Medication may reduce symptom severity enough that a person can engage at all. It is difficult to practice a demanding technique while severely unwell. Psychological treatment may address the maintaining factors medication does not reach. Avoidance, rumination, circumstances. And it may reduce relapse after medication is withdrawn. Now the decision process, and where the person enters it. Assessment and formulation come first. That is clinical work preceding any choice. Then option discussion. Then a trial, then review, then adjustment. And notice where the person's own priorities enter. At the discussion of options. Before a treatment is started, and not after it has been tried. Adjustment loops back to a shared decision, rather than proceeding unilaterally. Shared decision-making is often described as offering a choice, which is not quite it. It is the pairing of two kinds of expertise. The clinician brings what the options are, and what each is likely to achieve and cost. The person brings which of those costs matter to them. Sedation is unacceptable to someone who drives for a living, and trivial to someone who does not.
Weighed
Every Merit Casts Its Own Shadow
Now weigh the biological approach, with merits and gaps given equal seriousness. Reduced blame is a real merit. A physical account places fault nowhere. It displaced older moral explanations. The corresponding limitation is genuinely counterintuitive. Biological explanations can in some circumstances increase rather than reduce stigma. And they are associated with greater pessimism about recovery. Treatment access is a second merit. It brought psychological conditions into general health care, where they can be treated. The limitation is that a medical framing can narrow attention to symptoms. And away from the circumstances producing them. Measurable targets are a third merit. Physiological processes can be measured and tested. The limitation is that current biomarkers have limited predictive value. None diagnoses a condition in this course, or predicts which treatment will work. Effectiveness for severe presentations is a fourth, and it is uneven across conditions. Side-effect burden is a real cost, carried by the person. And mechanistic explanation is a fifth merit, limited by the correlate-versus-cause problem. Most biological findings remain associations. Read any single row across, and notice the shape. The limitation is not an objection to the merit. It is its shadow. The same feature produces both. The first row deserves elaboration, because it is the most surprising. Biological explanation does reduce the attribution of blame. It can simultaneously increase the perception that a person is fundamentally different. And that their condition is fixed, which predicts greater social distance. The implication is not to abandon biological explanation, but to pair it with plasticity. Conditions are physical, and the physical substrate changes.
A Composite Case
What a Course of Combined Treatment Looks Like
One composite case, constructed for instruction, describing no real person. Harjit is thirty-eight, and presents with a severe depressive presentation. Persistent low mood, loss of interest, disturbed sleep, marked slowing. And difficulty concentrating. The current episode has lasted five months, and he had one previous episode six years ago. Medical rule-out was completed, and found nothing relevant. He is on extended leave from work, and describes being unable to follow a page of reading. At option discussion, the benefits, timescales, and likely unwanted effects were set out. Harjit raised two concerns. That he did not want to be on treatment indefinitely. And that he doubted he could engage with a talking treatment in his current state. Both were taken as information rather than as obstacles. Medication from an antidepressant class was started, with the response lag explained first. Over the first two weeks he reported nausea and no mood change. That had been anticipated, and it was the reason he continued. By week five, his sleep and concentration had improved enough that reading was possible. Psychological treatment then began. Addressing his withdrawal from activity, and his conviction that colleagues thought less of him. Those are maintaining factors that medication does not reach. At each review, three things were assessed rather than one. Symptom change, burden of unwanted effects, and function. Function is why the review is not simply a symptom count. His returning to part-time work mattered more to him than any scale. Now note what the case does not show. It does not show that medication caused the improvement. There is no control, and every artifact of an uncontrolled claim applies to a single case.
About Abnormal Psychology at UPI Study
Abnormal Psychology (Psychology 180) is a self-paced online course of 97 video lessons in 25 chapters, from the main theoretical perspectives and clinical assessment to anxiety, mood, psychotic and personality disorders, treatment and the law. It carries a NCCRS credit recommendation for 3 semester credits.
Every lesson transcript is free on pages like this one, and the videos are free with a free UPI Study account. Enrolling adds a practice quiz after each lesson, the graded work and final exam that earn the credit, lifetime access, and an official transcript on completion. UPI Study has helped over 130,000 students with college credits. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Enroll now → Course details Download the syllabus All Psychology and social science courses Every course with PRO →
Why take it here
Why students take Abnormal Psychology with UPI Study
Where the credit goes
Universities that work with NCCRS
Abnormal Psychology carries a NCCRS credit recommendation. These universities work with NCCRS; some are UPI Study's signed partners. ACE and NCCRS have over 2,100 cooperating colleges that will consider accepting credits; the final decision is with the universities.
Thomas Edison State UniversitySigned partner
University of the PeopleSigned partner
Charter Oak State CollegeSigned partner
Strayer UniversitySigned partner
Columbia Southern UniversitySigned partner
Indiana TechSigned partner
Penn StateWorks with NCCRS
Southern New Hampshire UniversityWorks with NCCRS
SUNYWorks with NCCRS
+many more cooperating universitiesFind my college →Find my college → Not listed? Ask Athena in the corner of this page, or book a 15-minute call.
FAQ
Questions students ask us
About Medically-Based Interventions, and Weighing the Biological Approach
What was psychosurgery, and why is it considered a cautionary tale?
What are the acute, continuation, and maintenance phases of psychiatric medication treatment?
Why is it unsafe to stop psychiatric medication suddenly?
How is modern electroconvulsive therapy different from how it is shown in movies?
About the Abnormal Psychology course
How many college credits is Abnormal Psychology?
How much does Abnormal Psychology cost and what is included?
Which universities accept UPI Study credits?
How long does Abnormal Psychology take?
How are the exams done?
How do my credits reach my college?
Ready for the full course? Earn 3 credits in Abnormal Psychology.
97 video lessons, a quiz after each one, and the graded work that earns the credit. Recommended for credit by NCCRS.
3 credits · NCCRSEnroll →